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Tsintzas K, Gallo W, Melander O, Thompson D, James LJ,
Johnson L, Betts JA. Effect of acute hypohydration on glycemic
regulation in healthy adults: a randomized crossover trial. J Appl
Physiol 126: 422–430, 2019. First published November 29, 2018;
doi:10.1152/japplphysiol.00771.2018.—The aim of this study was to
investigate the acute effect of hydration status on glycemic regulation
in healthy adults and explore underlying mechanisms. In this random-
ized crossover trial, 16 healthy adults (8 men, 8 women) underwent an
oral glucose tolerance test (OGTT) when hypohydrated and rehy-
drated after 4 days of pretrial standardization. One day before OGTT,
participants were dehydrated for 1 h in a heat tent with subsequent
fluid restriction (HYPO) or replacement (RE). The following day, an
OGTT was performed with metabolic rate measurements and pre- and
post-OGTT muscle biopsies. Peripheral quantitative computer tomog-
raphy thigh scans were taken before and after intervention to infer
changes in cell volume. HYPO (but not RE) induced 1.9% (SD 1.2)
body mass loss, 2.9% (SD 2.7) cell volume reduction, and increased
urinary hydration markers, serum osmolality, and plasma copeptin
concentration (all P  0.007). Fasted serum glucose [HYPO 5.10
mmol/l (SD 0.42), RE 5.02 mmol/l (SD 0.40); P  0.327] and insulin
[HYPO 27.1 pmol/l (SD 9.7), RE 27.6 pmol/l (SD 9.2); P  0.809]
concentrations were similar between HYPO and RE. Hydration status
did not alter the serum glucose (P  0.627) or insulin (P  0.200)
responses during the OGTT. Muscle water content was lower before
OGTT after HYPO compared with RE [761 g/kg wet wt (SD 13) vs.
772 g/kg wet wt (SD 18) RE] but similar after OGTT [HYPO 779
g/kg wet wt (SD 15) vs. RE 780 g/kg wet wt (SD 20); time P 0.011;
trial  time P  0.055]. Resting energy expenditure was similar
between hydration states (stable between1.21 and 5.94 kJ·kg1·day1;
trial P  0.904). Overall, despite acute mild hypohydration increasing
plasma copeptin concentrations and decreasing fasted cell volume and
muscle water, we found no effect on glycemic regulation.
NEW & NOTEWORTHY We demonstrated for the first time that an
acute bout of hypohydration does not impact blood sugar control in
healthy adults. Physiological responses to mild hypohydration (2%
body mass loss) caused an elevation in copeptin concentrations
similar to that seen in those with diabetes as well as reducing cell
volume by ~3%; both of these changes had been hypothesized to
cause a higher blood sugar response.
copeptin; glycemia; health; hydration; metabolism
INTRODUCTION
Although it is well established that several dietary factors are
implicated in glycemic regulation, research into the effects of
hydration status is lacking. Observationally, plain water intake is
typically associated with better glycemic regulation (6, 7, 26),
which suggests that this could represent an inexpensive and
time-efficient health intervention. However, rather than demon-
strating a causal relationship, such associations may reflect water
intake being a marker of a generally healthy lifestyle encompass-
ing higher fiber intake and physical activity (19).
Understanding how hydration status impacts glycemia has
consequences for both clinical practice and research, whereby
fasted glucose concentrations and oral glucose tolerance tests
(OGTTs) are commonly used for diabetes diagnostics or to
ascertain the efficacy of an intervention. Standardization of
food and fluid intake before these measures is required to
prevent confounding influences, yet hydration status is not
uniformly controlled for, despite studies in adults with type 1
and 2 diabetes finding higher glycemic responses when partic-
ipants were hypohydrated vs. euhydrated (5, 18). One study
has also shown a similar deterioration in fasting glucose in
healthy adults when manipulating extracellular osmolality,
which mimics some of the physiological effects of hypohydra-
tion (20). Yet the effect of directly manipulating hydration
status on glycemic control in healthy adults has, to our knowl-
edge, never been investigated.
There are several causal mechanisms through which hydra-
tion status could influence glycemia (6). Briefly, hypohydration
decreases cell volume, which has been hypothesized to influ-
ence glucoregulation (16, 20). Serum osmolality and arginine
vasopressin (AVP) concentrations concurrently increase, po-
tentially stimulating hepatic glucose output via V1aR binding
in the liver (21, 29) and/or via adrenocorticotropic hormone
(ACTH) and cortisol secretion. Accordingly, high plasma co-
peptin (a surrogate marker of AVP) concentrations (10.70
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pmol/l in men and 6.47 pmol/l in women) have been asso-
ciated with worse cardiometabolic health outcomes compared
with those with low copeptin concentrations (4.59 pmol/l and
2.71 pmol/l, respectively) (10, 11).
Considering the implications for clinical practice, research,
and public health, we conducted a pilot study (n  5) in which
~12-h hypohydration (sauna plus fluid restriction) induced a
higher glycemic response to an OGTT compared with sauna
plus fluid replacement (8). Such findings warranted further
exploration in a tightly controlled study. Therefore we aimed to
investigate the role of hydration status in glycemic regulation
as well as examine key mechanisms (change in cell volume and
AVP secretion), hypothesizing that compared with rehydration
hypohydration would cause a higher glycemic response to an
OGTT.
METHODS
Participants
Sixteen healthy adults volunteered to participate (n  8 men, 8
women), with mean age of 30 yr (SD 9), body mass of 71.7 kg (SD
9.6), and body mass index of 24.0 kg/m2 (SD 3.4). Participants were
randomized with simple randomization (no strata) by H. A. Carroll
upon consent with a random number generator (Excel 2013, Mi-
crosoft). Exclusion criteria were age  18 yr or  60 yr, metabolic
disease (no body mass restrictions, except self-reported weight loss 
5 kg in previous 6 mo), drug dependence, and pregnancy/breastfeed-
ing; thus all participants were considered healthy and not taking
medication or necessary supplements (except contraceptives). Women
not taking continuous hormonal contraceptives were tested during
their estimated follicular phase (3–10 days after onset of menses).
Data were collected in South West England between June 2016 and
January 2017, inclusive. Participants provided written informed con-
sent.
The sample size estimate was based on our pilot project in five
participants (8) showing the largest magnitude of effect at 45 min after
glucose ingestion (d  1.1 mmol/l). The standard deviation at this
time point in the control (rehydration) group was also 1.1 mmol/l,
resulting in an effect size (dz) of 1. To provide a 95% power () to
detect this effect at an  (P) of 0.05 with a two-tailed paired t-test
required 16 participants.
Experimental Design
This was a randomized crossover trial, with 5- to 35-day washout
to account for the menstrual cycle where applicable. Each trial arm
consisted of 3 days of between-trial physical activity and diet repli-
cation (“pretrial monitoring phase”), a within-participant standardized
“intervention day,” and a full “laboratory testing day” (as detailed
below and in Fig. 1; trial registration can be found at Clinicaltrials-
.gov: NCT02841449 and Open Science Framework: https://osf.io/
ptq7m; deviations from the registered protocol are explained in full in
the data set available at https://researchdata.bath.ac.uk/id/eprint/547).
The research received ethical approval from National Health Service
Health Research Authority Frenchay (ref: 16/SW/0057) and was
conducted in accordance with the Declaration of Helsinki.
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Fig. 1. Protocol schematic. Resting metabolic rate (RMR) at 30 min taken in subsample (n 9). BM, body mass; BW, body water; OGTT, oral glucose tolerance
test; pQCT, peripheral quantitative computer tomography scan; Uosm, urine osmolality; USG, urine specific gravity. *Muscle biopsies were taken only in those
who opted in.
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Pretrial Monitoring Phase
Three days before trial, participants were asked to replicate their
food and fluid intake (weighed food and fluid intake diaries; analyzed
with Nutritics Nutrition Analysis Software, Nutritics, Dublin, Ireland)
and physical activity (combined heart rate and accelerometry; Acti-
heart; CamNtech, Cambridge, UK), morning body mass (Inner scan
body composition monitor model BC-543; Tanita) and urine specific
gravity (Table 1). On the third monitoring day, participants were
instructed to limit activity and to consume 40 ml/kg lean body mass
(assessed via bioelectrical impedance) of nonalcoholic fluid to ensure
euhydration before starting the intervention. This is in line with
previous research aiming to achieve euhydration (9, 22). No restric-
tions were placed on caffeinated beverages during this phase, although
it was emphasized to participants that they would need to replicate
their fluid intake in the subsequent trial arm.
Diet diaries were analyzed by the same coder within participant,
and accuracy was verified by the lead author. Coding discrepancies
were shared among all diet analysts to help ensure consistency
between participants. Nutrient intakes for each day of diet recording
were taken from the software and an average created for each
participant. Physical activity energy expenditure was analyzed with
Actiheart 4 software, which utilizes a two-branch equation to estimate
physical activity energy expenditure based on heart rate and acceler-
ometry. Each Actiheart was calibrated against measured resting met-
abolic rate for each participant and energy expenditure calculated with
the “Group Cal JAP 2007” model. Physical activity energy expendi-
ture for each day was then averaged for each participant.
Experimental Protocol
Intervention day. After the pretrial monitoring phase, participants
came to the laboratory between 0600 and 1000 in a euhydrated state,
following overnight fluid and food abstention from 2200 the previous
day. A peripheral quantitative computer tomography (pQCT; Stratec,
Pforzheim, Germany) scan of a cross section of the midpoint of the
right thigh was taken as a proxy for muscle cell volume, after which
a 10-ml euhydrated baseline blood sample was taken from an ante-
cubital vein. Blood analytes from this venipuncture further confirmed
compliance with the pretrial monitoring phase, showing that partici-
pants were in a similar metabolic state before starting each trial arm
(Table 2).
Participants then sat in a heat tent [hypohydrated trial arm (HYPO)
45.2°C (SD 1.6), rehydrated trial arm (RE) 44.6°C (SD 1.3); P 
0.292] wearing a sweat suit (RDX EVA Nylon Sauna Sweat Suit) for
60 min. Participants were nude weighed three times (Seca 803; Seca,
Birmingham, UK) immediately before and after the heat tent to
determine body water losses. After the heat tent, participants were
provided with a sandwich containing 1 g salt (Co-Operative Group)
of their choosing [standardized within participant; sandwiches con-
tained 1.5 g (SD 0.5), range 1.1–2.4 g], to maximize fluid retention
and serum osmolality changes (17), and either 3 ml/kg body mass
(HYPO) or 40 ml/kg lean body mass plus 150% sweat losses (RE) of
plain water to replace losses and account for the increased drink-
induced diuresis (12). All other fluids were prohibited, including those
containing caffeine and alcohol. Participants were only allowed to eat
from a list of low-water-content foods (e.g., pizza, biscuits, nuts;
avoiding fruit, vegetables, soups, and other fluids). Physical activity
energy expenditure and nutrient intake profiles were similar during the
intervention day (all measured nutrients P  0.102), except water
intake [HYPO 0.52 l/day (SD 0.11) vs. RE 3.7 l/day (SD 0.8); P 
0.001], confirming compliance with the protocol.
Laboratory testing day. Participants arrived at the laboratory be-
tween 0700 and 0730 after overnight food and fluid abstention from at
least 2200 the previous day, provided a urine sample, and had their
body mass recorded (Inner scan; body composition monitor, model
BC-543, Tanita). A second pQCT scan of the midpoint of the right
thigh was taken, after which participants were asked to rest semisu-
pine for 10–15 min. Their resting metabolic rate was recorded via
indirect calorimetry from gaseous exchange (13), whereby 2  5-min
measures were taken. Expired gas samples were collected in a Doug-
las bag (Hans Rudolph, Kansas City, KS) through Falconia tubing
(Baxter, Woodhouse and Taylor, Macclesfield, UK). Inspired air was
simultaneously measured to adjust for ambient O2 and CO2 concen-
trations (4). Inspired and expired O2 and CO2 concentrations were
measured with paramagnetic and infrared analyzers (Mini HF 5200;
Servomex Group, Crowborough, UK). For metabolic rate data n 14,
as two participants were excluded from all metabolic rate and respi-
ratory exchange ratio analyses because of fasted values  1, which
appeared to be caused by hyperventilation at these time points. In a
subgroup of participants (n 9) an additional 5-min Douglas bag was
taken at 25–30 min after glucose ingestion to establish whether the
initial diet-induced thermogenesis trend was linear between 0 and 60
min.
Participants then placed their hand in a hotbox (Medical Engineer-
ing Unit, University of Nottingham) set to 55°C for 5 min before an
indwelling cannula was fitted in an antecubital vein and a fasted blood
sample was drawn. An opt-in muscle biopsy was taken (n  9),
followed by a second fasted blood sample to quantify any changes
from the expected stress response of the biopsy. The muscle samples
were acquired via an ~3-mm incision at the anterior aspect of the thigh
under local anesthetic (lidocaine 1%, without epinephrine; Hameln
Pharmacueticals, Brockworth, UK) from the vastus lateralis by per-
cutaneous needle biopsy technique (3). Samples were immediately
removed from the needle and snap frozen in liquid nitrogen before
storage at 80°C.
A 75-g OGTT (Polycal; Nutricia) was subsequently conducted.
Arterialized venous blood samples (10 ml) were drawn at 15-min
intervals for 120 min. Expired gas samples (1  5-min Douglas bag
Table 1. Lifestyle factors and markers of hydration status
during 3-day pretrial monitoring phase
Hypohydration Rehydration P Value*
Energy intake, kJ/day 9,777 (SD 3,765) 10,091 (SD 3,513) 0.541
Carbohydrate, g/day 274 (SD 125) 271 (SD 125) 0.829
Fat, g/day 84 (SD 51) 93 (SD 53) 0.258
Protein, g/day 105 (SD 52) 103 (SD 41) 0.729
Sodium, mg/day 2,487 (SD 1,774) 2,497 (SD 1,156) 0.970
Potassium, mg/day 3,486 (SD 3,417) 2,778 (SD 1,347) 0.128
Water, l/day (food 	 fluid) 3.3 (SD 1.5) 3.2 (SD 1.4) 0.315
Physical activity energy
expenditure, kJ/day 4,462 (SD 2,276) 4,314 (SD 1,764) 0.381
Body mass, kg 71.7 (SD 9.6) 71.8 (SD 9.8) 0.340
Body mass index, kg/m2 23.6 (SD 4.2) 23.2 (SD 4.8) 0.409
USG 1.018 (SD 0.005) 1.018 (SD 0.005) 0.932
Values are means [standard deviation (SD)]; n  16. USG, urine specific
gravity. *Statistical significance calculated with 2-tailed paired t-test.
Table 2. Overnight fasted concentrations of blood hormones
and metabolites in euhydrated state at baseline before each
trial arm
Prehypohydration Prerehydration P Value*
Plasma ACTH, pmol/l 3.54 (SD 1.98) 3.61 (SD 1.48) 0.841
Plasma copeptin, pmol/l 4.45 (SD 2.01) 4.25 (SD 1.83) 0.462
Plasma cortisol, nmol/l 316 (SD 162) 330 (SD 269) 0.687
Serum glucose, mmol/l 5.04 (SD 0.30) 4.98 (SD 0.46) 0.493
Serum insulin, pmol/l 30.4 (SD 11.3) 29.8 (SD 11.0) 0.852
Serum osmolality, mosmol/kg 287 (SD 6) 285 (SD 4) 0.152
Values are means [standard deviation (SD)]; n  16. ACTH, adrenocorti-
cotropic hormone. *Statistical significance calculated with 2-tailed paired
t-test.
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as described above) were collected hourly. A second muscle biopsy
was then taken (for those who had opted in; n  7) after 120 min.
Muscle Water Content Analysis
Total muscle water content was determined by weighing the biopsy
samples before and after freeze drying (23). Samples were weighed on
a high-precision (resolution 0.01 mg) electronic balance (Mettler
Toledo AE240) while frozen (wet weight). The time elapsed between
sample removal from storage and weighing was fixed and recorded to
allow for standardization of tissue water evaporation. Samples were
then freeze dried with a LyoDry Compact (MechaTech Systems)
freeze dryer for 24 h at 55°C before being weighed again (dry
weight) with the same precision balance. Total muscle water content
was calculated as grams of water per kilogram of wet muscle with the
following equation: (wet weight  dry weight/wet weight)  1,000.
Biochemical Analysis
Six milliliters of blood was decanted into two EDTA tubes and
spun for 10 min at 2,500–3,446 g at 4°C. The remaining 4 ml of blood
was decanted into a serum tube, left for at least 30 min at room
temperature, and then spun as per the plasma. The plasma and serum
were divided into aliquots in separate Eppendorf tubes and frozen at
20°C before being moved to a 80°C freezer for longer-term
storage.
Metabolites and hormones were measured with commercially
available ELISAs (plasma arginine8 vasopressin, Enzo Life Sciences;
serum insulin, Mercodia), electrochemiluminescence immunoassays
(plasma ACTH and cortisol, Roche), automated immune analyzers
(plasma copeptin, ThermoFisher Kryptor Compact Plus), and spec-
trophotometric assays (serum glucose, RX Daytona, Randox Labora-
tories). Osmolality was measured with freezing-point depression (se-
rum osmolality, Gonotec Osmomat auto; urine osmolality, Micro-
Osmometer 3300), and urine specific gravity was measured with a
handheld refractometer (SUR-NE Clinical Refractometer; Atago).
Statistical Analysis
The primary aim of the study was to investigate the glycemic
response to an OGTT. Secondary outcomes were the insulin, vaso-
pressin (copeptin), rested energy expenditure, and substrate utilization
responses to the OGTT and the change in urine osmolality, urine
specific gravity, cell volume, serum osmolality, and muscle water
content from the intervention. We were additionally able to investi-
gate ACTH and cortisol.
Data were analyzed with paired-samples t-test or two-way repeated
measures (trial, time, trial  time) analysis of variance or appropriate
nonparametric tests (SPSS, version 22; IBM). Normality was checked
visually via P-P plots, histograms of standardized residuals, and
scatterplots of the standardized predicted vs. residual values. Asphe-
ricity was determined with Greenhouse-Geisser epsilon; values 
0.75 were corrected for with Greenhouse-Geisser correction and
values  0.75 with Huynh-Feldt correction. Total area under the
curve (AUC) and incremental AUC (iAUC) were calculated as per
Wolever (30). Analyses were repeated excluding those who had
muscle biopsies to explore whether their inclusion skewed the overall
findings. All analyses were two tailed with an  level of 0.05.
RESULTS
Markers of hydration status (body mass, urine specific grav-
ity, urine osmolality, and cross-sectional muscle area) sug-
gested compliance with both the HYPO and RE protocols
(Table 3).
Serum Glucose Concentration
Fasting serum glucose concentrations were similar between
HYPO [5.10 mmol/l (SD 0.42)] and RE [5.02 mmol/l (SD
0.40); P  0.327]. There were no differences in the glycemic
response between HYPO and RE during the OGTT (trial
F  0.246, P  0.627; time F  41.128, P  0.001; trial 
time F  0.944, P  0.430; Fig. 2A). No differences were
found in the serum glucose iAUC [HYPO 303 mmol·120
min·l1 (SD 121), RE 306 mmol·120 min·l1 (SD 113); P 
0.866], AUC [HYPO 926 mmol·120 min·l1 (SD 169), RE 934
mmol·120 min·l1 (SD 120); P  0.819], or time to peak
[HYPO 46 min (SD 14), RE 48 min (SD 14) min; P  0.609].
Serum Insulin Concentration
Serum insulin concentrations were similar in the fasted state
[HYPO 27.09 pmol/l (SD 9.66), RE 27.62 pmol/l (SD 9.21);
P  0.809]. During the OGTT, there were no differences
between HYPO and RE in the insulinemic response (trial
F  1.800, P  0.200; time F  29.597, P  0.001; trial 
time F  0.232, P  0.859; Fig. 2B). There were no differ-
ences in the iAUC [HYPO 20,860 pmol·120 min·l1 (SD
8,311), RE 21,937 pmol·120 min·l1 (SD 8,340); P  0.369],
AUC [HYPO 23,958 pmol·120 min·l1 (SD 9,275), RE 25,326
mmol·120 min·l1 (SD 8,679); P  0.359], or time to peak
[HYPO 54 min (SD 25), RE 58 min (SD 26);  P  0.633]
serum insulin concentrations.
Serum Osmolality
There was an increase from baseline in serum osmolality
during HYPO of 9 mosmol/kg (SD 6), with relative stability
from baseline during RE [
 1 mosmol/kg (SD 4); HYPO vs.
RE P 0.001; Table 3). Similar differences remained through-
out the OGTT (trial F  74.457, P  0.001), reflected in a
Table 3. Markers of hydration status between morning of intervention day (euhydrated state) and full laboratory testing day
Hypohydration Rehydration Pdifference
BL [mean (SD)] FT [mean (SD)]

 BL to FT HYPO
[mean (95% CI)] BL [mean (SD)] FT [mean (SD)]

 BL to FT RE
[mean (95% CI)]
BL HYPO
vs. RE*
FT HYPO
vs. RE*
Body mass, kg 71.6 (SD 9.8) 70.3 (SD 9.7) 1.3 (1.8, 0.8) 71.5 (SD 9.8) 71.4 (SD 9.9) 0.1 (0.3, 0.1) 0.675 0.001
Body water, kg 37.3 (SD 7.0) 36.8 (SD 6.5) 0.4 (0.8, 0.0) 37.6 (SD 5.8) 37.8 (SD 5.3) 0.1 (0.3, 0.6) 0.669 0.226
CSMA, mm2 12,773 (SD 2,829) 12,408 (SD 2,662) 365(587, 138) 12,682 (SD 2,684) 12,688 (SD 2,739) 6 (137, 148) 0.304 0.002
USG 1.017 (SD 0.005) 1.027 (SD 0.003) 0.010 (0.007, 0.014) 1.013 (SD 0.005) 1.016 (SD 0.003) 0.003 (0.000, 0.005) 0.017 0.001
Urine osmolality,
mosmol/kg 554 (SD 185) 965 (SD 84) 442 (355, 529) 419 (SD 147) 532 (SD 126) 93 (9, 178) 0.023 0.001
Values are means [standard deviation (SD] or means [95% confidence interval (CI)]. BL, euhydrated baseline measurement from the morning of the
intervention day; CSMA, cross-sectional muscle area; HYPO, hypohydrated trial arm; FT, full trial day; RE, rehydrated trial arm; USG, urine specific gravity.
*Statistical significance calculated with paired t-test.
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greater AUC during HYPO compared with RE [HYPO 35,355
mosmol·120 min·l1 (SD 692), RE 34,232 mosmol·120
min·l1 (SD 701); P  0.001].
Plasma Copeptin Concentration
Because of the difficulties in measuring AVP (24), our data
were unreliable but are available in the data set archived at
https://researchdata.bath.ac.uk/id/eprint/547. Plasma copeptin
was measured as a reliable marker of AVP secretion (24).
Fasted (prebiopsy) plasma copeptin concentrations increased
significantly from baseline after HYPO [
 14.32 pmol/l (SD
9.32); P  0.001] but not after RE [
 0.46 pmol/l (SD 2.34);
P  0.457]. Plasma copeptin concentrations were consistently
higher throughout the OGTT during HYPO compared with RE
(trial F  14.193, P  0.002; time F  1.285, P  0.282;
trial  time F  1.396, P  0.261; Fig. 3A), confirmed by a
higher AUC [HYPO 2,704 pmol·120 min·l1 (SD 2,398), RE
961 pmol·120 min·l1 (SD 1,488); P  0.001].
Plasma ACTH Concentration
There were no differences in the ACTH response between
HYPO and RE (trial F  2.541, P  0.132; time F  6.120,
P  0.025; trial  time F  1.343, P  0.266) during the
OGTT, nor were there differences in the AUC [HYPO 405
pmol·120 min·l1 (SD 195), RE 468 pmol·120 min·l1 (SD
255); P  0.121].
Plasma Cortisol Concentration
Plasma cortisol concentrations were similar between HYPO
and RE (trial F  0.216, P  0.649; time F  19.416, P 
0.001; trial  time F  0.275, P  0.674), with no differences
in the plasma cortisol AUC [HYPO 35,445 nmol·120 min·l1
(SD 17,432), RE 36,716 nmol·120 min·l1 (SD 24,915); P 
0.642].
Cross-Sectional Muscle Area
Cross-sectional muscle area as a proxy for muscle cell
volume reduced significantly from baseline after HYPO [

2.9% (SD 2.7); P  0.003] but not after RE [
 0.0% (SD
2.1) P  0.936; Table 3).
Muscle Water Content
Pre-OGTT muscle biopsies showed that muscle water con-
tent was lower during HYPO [760.5 g/kg (SD 13.2)] compared
with RE [771.6 g/kg (SD 17.8)], but this difference dissipated
after OGTT [HYPO 778.6 g/kg (SD 15.1), RE 780.2 g/kg (SD
20.0); trial F  3.183, P  0.135; time F  15.36, P  0.011;
trial  time F  6.265, P  0.055; Fig. 4).
Resting Energy Expenditure
Resting metabolic rate was similar between trial arms in the
fasted [HYPO 96.32 kJ·kg1·day1 (SD 11.94), RE 95.11
kJ·kg1·day1 (SD 13.09), P  0.400] and postprandial (trial
F  0.015, P  0.904; time F  10.130, P  0.001; trial 
time F  0.140, P  0.798) states. Participants had similar
fasting respiratory exchange ratios [HYPO 0.84 (SD 0.05), RE
0.84 (SD 0.06); P  0.900], although carbohydrate oxidation
after glucose ingestion had a tendency to increase to a greater
extent in the RE trial at 60 min [HYPO 0.88 (SD 0.04), RE
0.93 (SD 0.09)] and 120 min [HYPO 0.87 (SD 0.07), RE 0.91
(SD 0.07); trial F  3.650, P  0.078; time F  14.693, P 
0.001; trial  time F  3.754, P  0.039].
Plasma Volume
Because of an error in postural control during the baseline
(euhydrated) venipuncture, the plasma volume data were in-
valid. We have included details of how plasma volume was
measured and the data obtained in the data set available at
https://researchdata.bath.ac.uk/id/eprint/547.
Sensitivity Analysis
Those who had muscle biopsies demonstrated a distinct
stress response in plasma copeptin (Fig. 3B), ACTH, and
cortisol concentrations (shown below). Removing those who
had any biopsies did not alter the findings.
Copeptin. Removing those who had any biopsies did not
meaningfully affect the trend in plasma copeptin concentration
throughout the OGTT (n  7; trial F  13.517, P  0.010;
time F  4.081, P  0.040; trial  time F  1.489, P 
0.262), although the overall AUC was lower [n  7; HYPO
11,916 pmol·120 min·l1 (SD 1,661), RE 390 pmol·120
min·l1 (SD 177); P  0.028].
ACTH. Removing those who had opted in for muscle biop-
sies eliminated the time effect and highlighted a small though
nonsignificant trend toward higher ACTH concentrations dur-
ing RE compared with HYPO (n  7; trial F  4.203, P 
0
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Fig. 2. Serum glucose (A; trial F  0.246, P  0.627; time F  41.128, P 
0.001; trial time F  0.944, P 0.430) and insulin (B; trial F  1.800, P
0.200; time F  29.597, P  0.001; trial  time F  0.232, P  0.859)
responses to a 75-g oral glucose tolerance test (n  16). Data are means and
normalized 95% confidence intervals. HYPO, hypohydrated trial arm; RE,
rehydrated trial arm.
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0.086; time F  0.989, P  0.361; trial  time F  1.729,
P 0.219). When biopsy participants were removed the AUCs
were lower [n 7; HYPO 292 pmol·120 min·l1 (SD 139), RE
355 pmol·120 min·l1 (SD 86); P  0.176], but there was still
no difference between HYPO and RE.
Cortisol. In accordance with the plasma copeptin and ACTH
responses, plasma cortisol concentration also increased after
biopsy. Removing these participants did not meaningfully alter
the results, although the time effect was no longer evident (n
7; trial F  0.278, P  0.617; time F  5.172, P  0.055;
trial  time F  0.260, P  0.686). Despite a postbiopsy peak
in plasma cortisol concentration, the AUC was higher when the
biopsy participants were removed [n  7; HYPO 37,920
nmol·120 min·l1 (SD 25,008), RE 40,989 nmol·120 min·l1
(SD 37,507); P  0.735], with no difference between HYPO
and RE.
Resting metabolic rate. In the subgroup who had the addi-
tional measurement at 30 min after glucose ingestion (n  9),
no difference in resting metabolic rate (trial F  0.346, P 
0.573; time F  6.087, P  0.009; trial  time F  0.586,
P  0.508) or respiratory exchange ratio (trial F  0.433, P 
0.529; time F  17.330, P  0.001; trial  time F  0.467,
P  0.607) was apparent according to hydration status.
DISCUSSION
This randomized crossover trial is the first to show that
neither fasted nor postprandial glycemia and insulinemia are
influenced by hydration status in healthy adults, contrary to our
hypothesis. The key implication of this work is that clinicians
and researchers may not have to control for hydration status
when investigating glycemic regulation in healthy adults. Par-
ticipants replicated their diet and activity 4 days before trial,
reducing known confounding influences. Average body mass
loss during HYPO was 1.9%, which is within the typical range
to induce thirst and is not uncommon in the general population
(2), increasing the external validity of these findings. In the
hypohydrated state, copeptin (a surrogate marker of AVP)
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Fig. 3. A: plasma copeptin response during an oral glucose tolerance test (n  16; trial F  14.193, P  0.002; time F  1.285, P  0.282; trial  time
F  1.396, P  0.261). B: plasma copeptin response during an oral glucose tolerance test, with those who had muscle biopsies on both trials (n  7) separated
from those who had no biopsies on either trial (n  7). For those who had biopsies a fasted blood sample was taken before the biopsy (time point “Pre-biopsy”)
and after the biopsy immediately before the glucose was ingested (time point “0”), and for those who did not have biopsies only 1 fasted sample was taken (time
point “0”). *P  0.050, **P  0.010 comparing hypohydrated trial arm (HYPO) and rehydrated trial arm (RE) (trial effect) after Bonferroni adjustment for
multiple comparisons. Error bars show normalized 95% confidence intervals.
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concentrations increased from levels seen in healthy adults to
levels reported in those at highest risk of metabolic syndrome
(10), with an accompanying reduction in muscle cell volume of
~3%, hypothesized to be detrimental to glycemic regulation
(16). Therefore the level of hypohydration achieved was suf-
ficient to induce physiological changes that theoretically have
meaningful health implications; such changes did not occur
when participants were rehydrated.
Despite these physiological changes hypothesized to cause
higher glycemia, fasted and postprandial glycemia were similar
between HYPO and RE. These results are in contrast to similar
work in those with diabetes (5, 18). In both previous studies,
participants were required to withdraw from diabetes medica-
tion; accordingly, Burge et al. (5) found higher glucosuria
when participants were euhydrated compared with hypohy-
drated, potentially explaining the lower glycemic response. As
this effect of glucosuria has previously been alluded to (31), it
is a possible (at least partial) explanation for the findings of
Johnson et al. (18). This hypothesis could be tested by com-
paring glycemic regulation in those with diabetes during med-
ication withdrawal versus prescription. Glucosuria should not
occur in healthy adults, potentially explaining why we did not
find a lower glycemia during RE compared with HYPO.
Similarly, our findings conflict with research in healthy
adults. Keller et al. (20) administered intravenous saline and/or
desmopressin to induce changes specifically in extracellular
osmolality, finding higher fasted glucose concentrations during
hyperosmolality. This method of dehydration, however, is not
representative of whole body water losses, potentially explain-
ing the discordance between our findings. The present study
also contradicts our own pilot work (8), most likely because of
the lack of rigorous pretrial standardization of diet (verbal 24-h
recall), physical activity (self-reported replication), and hydra-
tion status (no preintervention measures) in the pilot.
A key mechanism by which elevations in AVP induce poor
glycemic control is through the hypothalamic-pituitary-adrenal
axis, stimulating ACTH and cortisol secretion. Despite the
increase we observed in plasma copeptin concentrations,
plasma ACTH and cortisol concentrations were not different
between HYPO and RE, suggesting that in healthy adults
short-term hypohydration is not a sufficient stimulus to induce
a stress response along the hypothalamic-pituitary-adrenal
axis. This theory is in accordance with earlier work highlight-
ing that the role of AVP in ACTH secretion is predominantly
a response to physical stress (15). Nevertheless, we did not find
a difference in ACTH or cortisol by hydration status in those
who had the muscle biopsies, despite higher copeptin re-
sponses during HYPO. In previous work in those with type 2
diabetes, cortisol concentrations did increase 45 min after
glucose ingestion when hypohydrated (18), perhaps suggesting
an interaction between hydration status and feeding in those
with metabolic impairments. However, as copeptin did not
increase postprandially in our study, the mechanism for this
cortisol response is unlikely to be AVP mediated.
Another mechanism proposed to link hypohydration to
higher glycemia is changes to cell volume influencing insulin
and glucagon secretion, although a limitation of our study is
that glucagon was not measured. Muscle cell volume was
reduced by ~3% from baseline, compared with no change
when participants were rehydrated—a reduction that may de-
teriorate glucose tolerance (16, 20). The pQCT data were
confirmed by the muscle biopsy samples, which showed lower
pre-OGTT total muscle water content in HYPO vs. RE. Inter-
estingly, after OGTT the muscle water content difference
diminished, suggesting that the introduction of glucose to the
cell created a strong enough stimulus to move water from other
compartments into skeletal muscle. Conversely, muscle water
content did not change from before to after OGTT during RE,
perhaps showing greater overall water balance as no extra
water was needed intracellularly for glycogen storage (25).
Hydration status could influence metabolic health over lon-
ger time periods by altering thermogenesis. Although it has
been shown, albeit inconsistently, that water ingestion induces
greater thermogenesis (27), our study did not support these
findings, supporting evidence that the thermogenic effect is
from consuming (cold) water rather than altering hydration
status (27). There was a tendency for higher carbohydrate
utilization during RE compared with HYPO, perhaps indicat-
ing greater hepatic glucose output during RE to account for the
higher carbohydrate utilization; however, these findings should
be interpreted cautiously, as the study was not powered for
these outcomes.
There are several other speculative theories that could ex-
plain our null findings that we did not test. First, it could be that
healthy adults have a greater capacity to handle metabolic
challenges such as acute bouts of hypohydration, and although
physiological changes occur to handle this flux, such devia-
tions ensure maintenance of homeostasis and therefore mini-
mize metabolic disruption. Accordingly, both serum osmolal-
ity and plasma copeptin concentrations increased during
HYPO vs. RE, suggesting higher AVP secretion to help main-
tain homeostasis. Considering that the level of HYPO we
induced is not uncommon in the population (2) and caused an
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Fig. 4. Average (thick lines) and individual (thin lines) muscle water content
before and after oral glucose tolerance test (OGTT) during hypohydrated trial
arm (HYPO; black) and rehydrated trial arm (RE; gray) (n  6; trial
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P  0.055). *P value Bonferroni adjusted for multiple comparisons.
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increase in copeptin concentrations associated with poor car-
diometabolic health (10, 11), it may be that such commonly
achieved levels of hypohydration have detrimental longer-term
health effects not captured by our acute study design.
A further hypothesis is that the conflicting roles of vasopres-
sin receptors (VRs) in adipose tissue insulin sensitivity led to
a null effect on glucose tolerance during HYPO. Specifically,
V1aR/ mice have reduced adipose tissue glucose tolerance,
whereas V1bR/ mice have increased adipose tissue insulin
sensitivity (1, 14, 28). If these findings translate into humans
(and assuming a similar propensity for VR binding), this could
mean that HYPO-induced AVP secretion, such as that
achieved in our study, leads to AVP binding on both V1aR and
V1bR, resulting in net zero effect on glycemic regulation.
However, the present study was not equipped to examine this
speculative theory.
Overall, despite physiologically and clinically meaningful
increases in plasma copeptin and serum osmolality, and a
notable reduction in cell volume supporting a systemic differ-
ence in hydration status between trial arms, we demonstrated
for the first time that acute hypohydration did not alter the
glycemic response. Our findings suggest that when OGTTs are
conducted in healthy adults hydration status may not necessar-
ily need to be strictly controlled for. Although longer-term
research is needed to understand the glucoregulatory effects of
chronic hypohydration, these data suggest that acute manipu-
lations of hydration status in healthy adults do not impact
fasted or postprandial glycemic regulation.
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